BrightSpring Health Services, Inc.
For the period ended Jun 30, 2026. Filed Jul 31, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Jul 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information.
Security Trading Plans of Directors and Executive Officers
On June 16, 2026, Scott Greenwell, Executive Vice President and President, PharMerica, entered into a stock trading plan designed to comply with Rule 10b5-1 under the Exchange Act (the “Rule 10b5-1 Plan”). The Rule 10b5-1 Plan provides for the sale, subject to certain price limits, of up to 11,973 shares of the Company’s common stock. The Rule 10b5-1 Plan has a trading effective date of September 14, 2026, and no sales are permitted to occur before this date. The Rule 10b5-1 Plan will terminateon September 14, 2026, unless terminated earlier pursuant to the terms of the Rule 10b5-1 Plan. If all shares aresold pursuant to the Rule 10b5-1 Plan, Mr. Greenwell will continue to satisfy the Company’s stock ownership guidelines.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.